Dibromomannitol therapy of chronic myelogenous leukemia during pregnancy.
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001966:Bromine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D007962:Leukocytes / Q000032:analysis / Q000201:enzymology; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D013997:Time Factors; D014805:Vitamin B 12 / Q000097:blood
D000970:Antineoplastic Agents; D008353:Mannitol; D000469:Alkaline Phosphatase; D014805:Vitamin B 12; D001966:Bromine